Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Merck
Dow
Colorcon

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE; LIXISENATIDE

See Plans and Pricing

« Back to Dashboard

INSULIN GLARGINE; LIXISENATIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi-aventis Us SOLIQUA 100/33 insulin glargine; lixisenatide SOLUTION;SUBCUTANEOUS 208673 NDA Sanofi-Aventis U.S. LLC 0024-5761-05 5 SYRINGE in 1 CARTON (0024-5761-05) > 3 mL in 1 SYRINGE
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Moodys
Colorcon
Baxter